|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 67.1 TWD | +4.19% |
|
+10.91% | +33.40% |
| 05-07 | TSH Biopharm Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 03-11 | TSH Biopharm Corporation Limited Announces Directorate Changes on April 1, 2024 | CI |
TSH Biopharm Corporation Limited announced directorate changes. Name, title, and resume of the previous position holder: Sze-Yuan Yang/General Manager. Name, title, and resume of the new position holder: Jung-Liang Kao/Senior Division Director of Finance Division and CFO of the Company.
The newly appointed spokesperson will take office on April 1, 2024.
| 1st Jan change | Capi. | |
|---|---|---|
| +33.40% | 76.32M | |
| +32.36% | 698B | |
| +26.51% | 568B | |
| -4.40% | 358B | |
| +19.46% | 328B | |
| +3.50% | 283B | |
| +16.34% | 238B | |
| +6.68% | 203B | |
| -9.08% | 198B | |
| +8.62% | 165B |
TSH BIOPHARM CORPORATION LIMITED 